Brief: Kintor Pharmaceutical Says Clinical Trial Of Proxa-Rescue Androcov Trial Of Proxalutamide Approved in Brazil
28/01/2021 15:04
Jan 28 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* CLINICAL TRIAL OF PROXA-RESCUE ANDROCOV TRIAL OF
PROXALUTAMIDE
APPROVED BY INSTITUTIONAL REVIEW BOARD OF BRAZIL
Source text for Eikon: ID:nHKS3SXjYb
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint